永茂泰(605208.SH):磊昶投資擬減持合計不超過698.48萬股
格隆匯5月26日丨永茂泰(605208.SH)公佈,自本公告披露之日起15個交易日後的3個月內,磊昶投資擬以集中競價交易方式減持不超過262.63萬股、以大宗交易方式減持不超過435.85萬股,合計不超過698.48萬股,約佔公司總股本的2.117%;宏芝投資擬以集中競價交易方式減持不超過67.31萬股、以大宗交易方式減持不超過111.7萬股,合計不超過179萬股,約佔公司總股本的0.543%。
磊昶投資、宏芝投資均成立於2016年1月,爲公司IP0前成立的員工持股平臺,此前從未減持。本次減持系員工基於自身情況及資金需求所作出的決策。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.